204 related articles for article (PubMed ID: 12924492)
1. Usefulness of [123I]metaiodobenzylguanidine ([123I]MIBG) myocardial scintigraphy in differentiating between Alzheimer's disease and dementia with Lewy bodies.
Oide T; Tokuda T; Momose M; Oguchi K; Nakamura A; Ohara S; Ikeda S
Intern Med; 2003 Aug; 42(8):686-90. PubMed ID: 12924492
[TBL] [Abstract][Full Text] [Related]
2. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.
Shimizu S; Hirao K; Kanetaka H; Namioka N; Hatanaka H; Hirose D; Fukasawa R; Umahara T; Sakurai H; Hanyu H
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):184-192. PubMed ID: 26233438
[TBL] [Abstract][Full Text] [Related]
3. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.
Tiraboschi P; Corso A; Guerra UP; Nobili F; Piccardo A; Calcagni ML; Volterrani D; Cecchin D; Tettamanti M; Antelmi L; Vidale S; Sacco L; Merello M; Stefanini S; Micheli A; Vai P; Capitanio S; Gabanelli SV; Riva R; Pinto P; Biffi AM; Muscio C;
Ann Neurol; 2016 Sep; 80(3):368-78. PubMed ID: 27398636
[TBL] [Abstract][Full Text] [Related]
4. Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease.
Hanyu H; Shimizu S; Hirao K; Kanetaka H; Iwamoto T; Chikamori T; Usui Y; Yamashina A; Koizumi K; Abe K
Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):248-53. PubMed ID: 16328506
[TBL] [Abstract][Full Text] [Related]
5. 123I-metaiodobenzylguanidine myocardial scintigraphy with early images alone is useful for the differential diagnosis of dementia with Lewy bodies.
Manabe Y; Inui Y; Toyama H; Kosaka K
Psychiatry Res Neuroimaging; 2017 Mar; 261():75-79. PubMed ID: 28152401
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis.
Slaets S; Van Acker F; Versijpt J; Hauth L; Goeman J; Martin JJ; De Deyn PP; Engelborghs S
Int J Geriatr Psychiatry; 2015 Aug; 30(8):864-9. PubMed ID: 25363642
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic markers for diagnosing dementia with Lewy bodies: CSF and MIBG cardiac scintigraphy study.
Wada-Isoe K; Kitayama M; Nakaso K; Nakashima K
J Neurol Sci; 2007 Sep; 260(1-2):33-7. PubMed ID: 17459416
[TBL] [Abstract][Full Text] [Related]
8. Comparison of (123)I-MIBG myocardial scintigraphy, brain perfusion SPECT, and voxel-based MRI morphometry for distinguishing between dementia with Lewy bodies and Alzheimer's disease.
Inui Y; Toyama H; Manabe Y; Sarai M; Iwata N
Ann Nucl Med; 2014 Oct; 28(8):796-804. PubMed ID: 24986482
[TBL] [Abstract][Full Text] [Related]
9. Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD.
Yoshita M; Taki J; Yokoyama K; Noguchi-Shinohara M; Matsumoto Y; Nakajima K; Yamada M
Neurology; 2006 Jun; 66(12):1850-4. PubMed ID: 16801649
[TBL] [Abstract][Full Text] [Related]
10. A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies.
Yoshita M; Taki J; Yamada M
J Neurol Neurosurg Psychiatry; 2001 Nov; 71(5):583-8. PubMed ID: 11606666
[TBL] [Abstract][Full Text] [Related]
11. The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and
Kobayashi S; Makino K; Hatakeyama S; Ishii T; Tateno M; Iwamoto T; Tsujino H; Kawasaki K; Mikuni K; Ukai W; Murayama T; Hashimoto E; Utsumi K; Kawanishi C
Psychogeriatrics; 2017 Jul; 17(4):247-255. PubMed ID: 28130808
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of probable or possible dementia with lewy bodies using 123I-IMP brain perfusion SPECT, 123I-MIBG, and 99mTc-MIBI myocardial SPECT.
Inui Y; Toyama H; Manabe Y; Sato T; Sarai M; Kosaka K; Iwata N; Katada K
J Nucl Med; 2007 Oct; 48(10):1641-50. PubMed ID: 17873141
[TBL] [Abstract][Full Text] [Related]
13. (123)I-MIBG myocardial scintigraphy and neurocirculatory abnormalities in patients with dementia with Lewy bodies and Alzheimer's disease.
Kim JS; Park HE; Oh YS; Song IU; Yang DW; Park JW; Lee KS
J Neurol Sci; 2015 Oct; 357(1-2):173-7. PubMed ID: 26208800
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Sensitivity and Symptomatic Relevance of Dopamine Transporter Imaging and Myocardial Sympathetic Scintigraphy in Patients with Dementia with Lewy Bodies.
Tang Z; Hirano S; Koizumi Y; Izumi M; Kitayama Y; Yamagishi K; Tamura M; Ishikawa A; Kashiwado K; Iimori T; Mukai H; Yokota H; Horikoshi T; Uno T; Kuwabara S
J Alzheimers Dis; 2024; 100(1):127-137. PubMed ID: 38848178
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study.
Yoshita M; Arai H; Arai H; Arai T; Asada T; Fujishiro H; Hanyu H; Iizuka O; Iseki E; Kashihara K; Kosaka K; Maruno H; Mizukami K; Mizuno Y; Mori E; Nakajima K; Nakamura H; Nakano S; Nakashima K; Nishio Y; Orimo S; Samuraki M; Takahashi A; Taki J; Tokuda T; Urakami K; Utsumi K; Wada K; Washimi Y; Yamasaki J; Yamashina S; Yamada M
PLoS One; 2015; 10(3):e0120540. PubMed ID: 25793585
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the usefulness of brain perfusion SPECT and MIBG myocardial scintigraphy for the diagnosis of dementia with Lewy bodies.
Tateno M; Kobayashi S; Shirasaka T; Furukawa Y; Fujii K; Morii H; Yasumura S; Utsumi K; Saito T
Dement Geriatr Cogn Disord; 2008; 26(5):453-7. PubMed ID: 18974648
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of dementia with Lewy bodies, Alzheimer's disease and vascular dementia by cardiac 131I-meta-iodobenzylguanidine (MIBG) uptake (preliminary report).
Jindahra P; Vejjajiva A; Witoonpanich R; Sirisriro R; Sritara C; Pulkes T
J Med Assoc Thai; 2004 Oct; 87(10):1176-81. PubMed ID: 15560694
[TBL] [Abstract][Full Text] [Related]
18. Clinical validity of presynaptic dopaminergic imaging with
Sonni I; Ratib O; Boccardi M; Picco A; Herholz K; Nobili F; Varrone A;
Neurobiol Aging; 2017 Apr; 52():228-242. PubMed ID: 28317651
[TBL] [Abstract][Full Text] [Related]
19. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.
Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K
J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056
[TBL] [Abstract][Full Text] [Related]
20.
Komatsu J; Samuraki M; Nakajima K; Arai H; Arai H; Arai T; Asada T; Fujishiro H; Hanyu H; Iizuka O; Iseki E; Kashihara K; Kosaka K; Maruno H; Mizukami K; Mizuno Y; Mori E; Nakamura H; Nakano S; Nakashima K; Nishio Y; Orimo S; Takahashi A; Taki J; Tokuda T; Urakami K; Utsumi K; Wada K; Washimi Y; Yamashina S; Yamasaki J; Yoshita M; Yamada M
J Neurol Neurosurg Psychiatry; 2018 Nov; 89(11):1167-1173. PubMed ID: 29853532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
